X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10207) 10207
Publication (1190) 1190
Newsletter (727) 727
Book Review (112) 112
Magazine Article (58) 58
Book Chapter (40) 40
Newspaper Article (31) 31
Dissertation (21) 21
Trade Publication Article (14) 14
Conference Proceeding (10) 10
Web Resource (9) 9
Paper (8) 8
Government Document (4) 4
Journal / eJournal (3) 3
Data Set (2) 2
Book / eBook (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
azithromycin (7752) 7752
humans (5941) 5941
index medicus (3404) 3404
female (3115) 3115
male (3108) 3108
anti-bacterial agents - therapeutic use (2632) 2632
azithromycin - therapeutic use (2397) 2397
infectious diseases (2065) 2065
adult (1995) 1995
microbiology (1853) 1853
pharmacology & pharmacy (1849) 1849
antibiotics (1582) 1582
anti-bacterial agents - pharmacology (1477) 1477
middle aged (1407) 1407
azithromycin - pharmacology (1213) 1213
animals (1151) 1151
azithromycin - administration & dosage (1141) 1141
research (1141) 1141
anti-bacterial agents - administration & dosage (1107) 1107
erythromycin (1078) 1078
treatment outcome (1068) 1068
microbial sensitivity tests (1062) 1062
clarithromycin (1060) 1060
adolescent (1043) 1043
child (974) 974
infections (957) 957
infection (929) 929
immunology (905) 905
aged (896) 896
drug therapy (808) 808
macrolides (788) 788
children (759) 759
health aspects (758) 758
medicine, general & internal (756) 756
care and treatment (726) 726
child, preschool (712) 712
risk factors (658) 658
analysis (642) 642
anti-bacterial agents - adverse effects (596) 596
dosage and administration (581) 581
therapy (577) 577
infant (572) 572
azithromycin - adverse effects (555) 555
pharmacokinetics (551) 551
drug resistance, bacterial (541) 541
respiratory system (529) 529
prevalence (524) 524
pediatrics (504) 504
resistance (500) 500
young adult (487) 487
ciprofloxacin (483) 483
diagnosis (471) 471
drug resistance (471) 471
pneumonia (465) 465
drug therapy, combination (460) 460
prevention (451) 451
research article (449) 449
antimicrobial resistance (439) 439
susceptibility (437) 437
bacteria (430) 430
mice (430) 430
administration, oral (427) 427
efficacy (426) 426
medical research (426) 426
doxycycline (425) 425
macrolide antibiotics (416) 416
inflammation (412) 412
epidemiology (408) 408
chlamydia trachomatis (404) 404
anti-bacterial agents - pharmacokinetics (400) 400
disease (400) 400
antimicrobial agents (393) 393
erythromycin - pharmacology (388) 388
abridged index medicus (384) 384
drug administration schedule (381) 381
chlamydia infections - drug therapy (379) 379
time factors (371) 371
macrolide (369) 369
medicine (363) 363
in-vitro (362) 362
clinical trials (350) 350
azithromycin - pharmacokinetics (349) 349
medicine, experimental (345) 345
retrospective studies (341) 341
double-blind (339) 339
cystic fibrosis (337) 337
trachoma (337) 337
drugs (332) 332
pregnancy (326) 326
prospective studies (325) 325
ophthalmology (323) 323
drug resistance in microorganisms (321) 321
mortality (317) 317
usage (315) 315
ceftriaxone (314) 314
dose-response relationship, drug (309) 309
double-blind method (308) 308
erythromycin - analogs & derivatives (306) 306
follow-up studies (298) 298
aged, 80 and over (297) 297
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10223) 10223
French (194) 194
Spanish (128) 128
German (116) 116
Japanese (104) 104
Russian (74) 74
Chinese (66) 66
Portuguese (37) 37
Italian (30) 30
Croatian (28) 28
Polish (23) 23
Korean (18) 18
Turkish (17) 17
Bulgarian (8) 8
Czech (6) 6
Danish (6) 6
Persian (6) 6
Norwegian (5) 5
Dutch (4) 4
Romanian (4) 4
Hungarian (3) 3
Finnish (2) 2
Hebrew (2) 2
Icelandic (2) 2
Slovak (2) 2
Swedish (2) 2
Ukrainian (2) 2
Bosnian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pharmacology and Therapeutics, ISSN 0163-7258, 08/2014, Volume 143, Issue 2, pp. 225 - 245
Journal Article
Azithromycin as treatment for Cryptosporidiosis in human immunodeficiency virus disease, 12/2002
Background: Cryptosporidiosis caused by the protozoa Cryptosporidium, is the common cause of diarrhoea in Acquired Immune Deficiency Syndrome (AIDS). Aim: To... 
Cryptosporidiosis, Azithromycin, AIDS
Journal
Study - Comparison of oral azithromycin pulse with daily doxycycline in the treatment of acne vulgaris, 12/2003
Introduction: Oral azithromycin has been advocated by some in the treatment of acne. However, its efficacy has not been established. Material and Methods: This... 
Azithromycin, Acne vulgaris, Doxycycline
Journal
by Miao, H and Liu, F-Z and Qi, Z-H
Xiandai Yaowu Yu Linchuang / Drugs & Clinic, ISSN 1674-5515, 05/2013, Volume 28, Issue 3, pp. 361 - 363
Objective To observe the effect of azithromycin combined with vaginal antibacterial gel in the treatment of female genital tract mycoplasma infection in... 
Azithromycin
Journal Article
Journal Article
Journal Article
Kemija u Industriji, ISSN 0022-9830, 12/2011, Volume 60, Issue 12, pp. 603 - 617
The invention of azithromycin (1, Figure 1), the active pharmaceutical ingredient of the antibiotic Sumamed (Croatian brand name by PLIVA; Zithromax by Pfizer... 
Azithromycin
Journal Article
Transplant International, ISSN 0934-0874, 10/2015, Volume 28, Issue 10, pp. 1131 - 1139
Journal Article
Journal of Cleaner Production, ISSN 0959-6526, 09/2019, Volume 232, p. 127
Sewage output contains a wide range of organic materials, such as pharmaceutical compounds. These compounds have harmful effects on the environment, such as... 
Pollution | Analysis | Azithromycin
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 2018, Volume 12, pp. 3855 - 3866
Background: The obnoxious bitter taste of orally taken antibiotics is one of the biggest problems in the treatment of children. The pediatric population cannot... 
Azithromycin–TiO2 nanohybrid | AZN | Azithromycin | TNPs | Dissolution | Physisorption | Titanium dioxide nanoparticles | CHEMISTRY, MEDICINAL | STABILITY | titanium dioxide nanoparticles | dissolution | NANOCRYSTALS | azithromycin | physisorption | FORMULATION | ADSORPTION | SOLUBILITY | NANOPARTICLES | IN-VITRO | azithromycin-TiOnanohybrid | ERYTHROMYCIN | PHARMACOLOGY & PHARMACY | OPTIMIZATION | FABRICATION | Azithromycin - chemistry | Titanium - pharmacology | Nanoparticles - chemistry | Humans | Molecular Conformation | Titanium - chemistry | Healthy Volunteers | Azithromycin - pharmacology | Particle Size | Taste - drug effects | Adsorption | Anti-Bacterial Agents - chemistry | Surface Properties | Anti-Bacterial Agents - pharmacology | Titanium | Health aspects | Titanium dioxide | Analysis | Fourier transforms | Adsorbates | X-ray diffraction | Dosage | Powder | Adsorbents | Nanoparticles | Aqueous solutions | Masking | Children | Psychological stress | Scanning electron microscopy | Stability | X ray powder diffraction | Bitter taste | Accelerated tests | Environmental factors | Liquid chromatography | High-performance liquid chromatography | Pharynx | Dispersion | Studies | Organic chemistry | Palatability | Antibiotics | Taste | Drying | Pediatrics | Particle size | Efficiency | Drug dosages | Pharmacy | Potassium | Pharmaceuticals | Titanium dioxide nanoparticles (TNP) | Physiosorption | Azithromycin (AZ) | Azithromycin- TiO2 Nanohybrid (AZN)
Journal Article